Skip to main content

22/04 20:13 CET

Novartis and GSK swap assets in pharma industry reshape

Novartis and GSK swap assets in pharma industry reshape

There has been a major shake-up in the drugmaking world. Swiss firm Novartis is selling its animal medicines division and swapping assets with Britain’s GlaxoSmithKline. It means GSK will no longer make anti-cancer drugs and it will acquire Novartis’ vaccines…


Log in
Please enter your login details